Short-term safety and tolerability profile of 5-methoxy-N,N-dimethyltryptamine in human subjects: a systematic review of clinical trials
IntroductionPsychedelic agents have regained the attention of pharmaceutical companies as promising treatments for depressive episodes. 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT), an atypical psychedelic, is emerging as a potentially effective, novel rapid-acting antidepressant. In this systematic...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2024-09-01
|
| Series: | Frontiers in Psychiatry |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1477996/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|